Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
NCT ID: NCT01086397
Last Updated: 2012-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
782 participants
OBSERVATIONAL
2010-02-28
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Etiology and Incidence Assessment of Radiographically-confirmed Community Acquired Pneumonia (CAP)
NCT03606135
A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
NCT00637351
A Global Active Surveillance for Community Acquired Pneumonia
NCT00929721
Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.
NCT01564771
Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala
NCT03696303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Urine sample collection
All subjects have non-invasive urine sample collection performed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Urine sample collection
All subjects have non-invasive urine sample collection performed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presents to a study site with clinically suspected pneumonia.
* Has a radiographic finding that is consistent with pneumonia.
* Able and willing to provide urine.
Exclusion Criteria
* Hospital-acquired pneumonia (ie, pneumonia developing 48 hours after hospital admission).
* Previous enrollment in this study within the past 30 days.
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Alabama Division of Clinical Research
Mobile, Alabama, United States
Sharpe-Grossmont Hospital
La Mesa, California, United States
Tampa General Hospital
Tampa, Florida, United States
Northwestern Memorial Hospital
Chicago, Illinois, United States
Baystate Infectious Diseases Clinical Research
Springfield, Massachusetts, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
Detroit Receiving Hospital
Detroit, Michigan, United States
Sinai Grace Hospital
Detroit, Michigan, United States
eStudySite
Las Vegas, Nevada, United States
Summa Infectious Diseases
Akron, Ohio, United States
Lehigh Valley Hospital
Allentown, Pennsylvania, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Sentara Norfolk General Hospital Cardiac Research 600 Gresh
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B1851032
Identifier Type: -
Identifier Source: secondary_id
6115A1-4007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.